LUNAR IIIb Study Comparing Rosuvastatin and Atorvastatin in Subjects With Acute Coronary Syndromes

AstraZeneca

Status and phase: Completed; Phase 3

Conditions: Acute Coronary Syndromes

Treatments: Drug: atorvastatin; Drug: rosuvastatin calcium

Study type: Interventional

Funder types: Industry

Identifiers

NCT00214630

4522US/0001

D3560L00021

LUNAR

Details and patient eligibility

About

Comparison of rosuvastatin and atorvastatin in subjects with acute coronary syndromes

Enrollment: 825 patients

Sex: All

Ages: 18 to 70 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Non-ST segment elevation ACS and ST segment elevation ACS who receive optimal reperfusion therapy

Exclusion criteria

• Previous Q-wave infarct within the last 4 weeks
• CK elevation not caused by myocardial injury
• uncontrolled hypertension at time of randomization

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)